Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Correction

Accepted on 09 Jul 2025

Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm

in Multiple Sclerosis and Neuroimmunology

Robert Hoffrogge
Anna Karachunskaya
Neele Heitmann
Steffen Haupeltshofer
Xiomara Pedreiturria
Katharina Klöster
Verian Bader
Konstanze Winklhofer
Michael Hamacher
Bert Klebl

Frontiers in Immunology

doi 10.3389/fimmu.2025.1652299

Original Research

Accepted on 07 Jul 2025

Single-nucleus RNA sequencing reveals the specific molecular signatures of myeloid cells responding to brain injury after microglial replacement

in Multiple Sclerosis and Neuroimmunology

Xiao-Yi Xiong
Haicheng Yuan
Ying Mu
Yi He
Fang Xie
Xiao-Shuang Feng
Jia-Xin Xie
Xin-Ru Pan
Yu-Fei Wang
Jian Gong

Frontiers in Immunology

doi 10.3389/fimmu.2025.1625673

Original Research

Published on 04 Jul 2025

Subcortical shape biomarkers reveal limbic and basal ganglia damage in anti-LGI1 encephalitis

in Multiple Sclerosis and Neuroimmunology

Jianping Qiao
Zhishun Wang
Jiaxiang Xin
Shengjun Wang
Anning Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1623577

413 views

Original Research

Accepted on 03 Jul 2025

Clinical characteristics of patients with GFAP-IgG coexisting with AQP4-IgG or MOG-IgG

in Multiple Sclerosis and Neuroimmunology

Qingchen Li
Xinyun Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1610486

117 views

Editorial

Published on 03 Jul 2025

Editorial: Community series in trends in neuroimmunology: cross-talk between brain-resident and peripheral immune cells in both health and disease, volume II

in Multiple Sclerosis and Neuroimmunology

Suryanarayan Biswal
Janina E. Borgonovo
Carlos L. Freites
Verónica Martínez-Cerdeño
Rajnikant Mishra
Shashank K. Maurya
Estela M. Muñoz

Frontiers in Immunology

doi 10.3389/fimmu.2025.1644278

460 views

Original Research

Published on 01 Jul 2025

T-cell repertoire correlates with cytokine imbalance in multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Lisa Weidner
Rodolphe Poupardin
Tobias Zrzavy
Sandra Laner-Plamberger
Georg Gratz
Tanja Eichhorn
Viktoria Weber
Paulus S. Rommer
Christof Jungbauer
Dirk Strunk

Frontiers in Immunology

doi 10.3389/fimmu.2025.1604452

638 views

Original Research

Published on 01 Jul 2025

Chronic ethanol administration exacerbates memory loss by altering N6-methyladenosine-mediated epigenetic signaling

in Multiple Sclerosis and Neuroimmunology

Yuanhang Liao
Fu Xu
Yuqing Yan
Sicheng Zhou
Na Liu
Baomin Dou
Nivetha Srinivasan
Weizheng Wang
Xiongwei Zhu
Jianghong Ye

Frontiers in Immunology

doi 10.3389/fimmu.2025.1455994

497 views

Original Research

Accepted on 30 Jun 2025

Reduced Tolerogenic Factor sCD83 in NMOSD and Relapsing MOGAD: A Potential New Therapeutic Pathway

in Multiple Sclerosis and Neuroimmunology

Ariel Rechtman
Omri Zveik
Lyne Shweiki
garrick Hoichman
Tal Friedman-korn
Livnat Brill
ADI Vaknin-Dembinsky

Frontiers in Immunology

doi 10.3389/fimmu.2025.1620069

147 views

Original Research

Published on 30 Jun 2025

Longitudinal immune profiling following autologous hematopoietic stem cell transplantation in multiple sclerosis: insights into immune reconstitution and disease modulation

in Multiple Sclerosis and Neuroimmunology

Malin Müller
Ivan Pavlovic
Anna Wiberg
Joachim Burman

Frontiers in Immunology

doi 10.3389/fimmu.2025.1601223

531 views

Original Research

Published on 30 Jun 2025

Understanding the microbiome in autologous haemopoietic stem cell transplant for multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Jun Yin
Nadeem O. Kaakoush
Jennifer Massey
Mark Danta

Frontiers in Immunology

doi 10.3389/fimmu.2025.1590601

634 views

Original Research

Published on 26 Jun 2025

Adherence to therapeutic recommendation in relapsing-remitting multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Justyna Chojdak-Łukasiewicz
Aleksandra Kołtuniuk
Ewa Sawicka
Anna Pokryszko-Dragan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1545430

494 views

Review

Published on 26 Jun 2025

Rational therapeutic targeting of myeloid cells in glioblastoma: challenges and perspectives

in Multiple Sclerosis and Neuroimmunology

Faruk Akay
Maya Saleh

Frontiers in Immunology

doi 10.3389/fimmu.2025.1472710

532 views

Original Research

Accepted on 20 Jun 2025

Exploring the Mycobiota in Multiple Sclerosis: Its Influence on Disease Development and Progression

in Multiple Sclerosis and Neuroimmunology

Ane Otaegui
Miriam Gorostidi Aicua
Laura Martins Almeida
Ainhoa Alberro Garitano
Leire Romarate García
Idoia Mendiburu Arrieta
Amaya Álvarez de Arcaya
Maialen Arruti Gonzalez
Tamara Castillo Triviño
David Otaegui

Frontiers in Immunology

doi 10.3389/fimmu.2025.1625794

276 views

Review

Published on 19 Jun 2025

Role of meningeal lymphatic vessels in brain homeostasis

in Multiple Sclerosis and Neuroimmunology

Meng-Ying Zhao
Chao-Yuan Ye
Yuan-Cheng Liu
Xiao-Ming Wang
Jun-Cai Fu
Xin-Yuan Liu
Rui Zhu
Yi-Zhao Li
Qing Tian

Frontiers in Immunology

doi 10.3389/fimmu.2025.1593630

969 views

Original Research

Published on 18 Jun 2025

The contribution of BTK signaling in myeloid cells to neuroinflammation

in Multiple Sclerosis and Neuroimmunology

Claudia Bassani
Marta Molinari
Valentina Romeo
Vittorio Martinelli
Ursula Boschert
Gianvito Martino
Luca Muzio
Cinthia Farina

Frontiers in Immunology

doi 10.3389/fimmu.2025.1595069

1,100 views

Mini Review

Published on 16 Jun 2025

Brain-derived blood biomarkers in multiple sclerosis—current trends and beyond

in Multiple Sclerosis and Neuroimmunology

Shamundeeswari Anandan
Karina Maciak
Regina Breinbauer
Sepideh Mostafavi
Christopher Elnan Kvistad
Oivind Torkildsen
Kjell-Morten Myhr

Frontiers in Immunology

doi 10.3389/fimmu.2025.1569503

1,176 views